A Pilot, Open-Label, Randomized, Crossover, Pharmacokinetic Study Of Enhanced Bioavailability Formulations Of Celecoxib In Healthy Volunteers.

Trial Profile

A Pilot, Open-Label, Randomized, Crossover, Pharmacokinetic Study Of Enhanced Bioavailability Formulations Of Celecoxib In Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Mar 2010

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Ankylosing spondylitis; Gouty arthritis; Juvenile rheumatoid arthritis; Musculoskeletal pain; Osteoarthritis; Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 12 Mar 2009 Actual initiation date (Jan 2009) added as reported by ClinicalTrials.gov.
    • 12 Mar 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Feb 2009 Planned initiation date changed from 1 Jan 2009 to 1 Feb 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top